Division of Pediatric Hematology/Oncology

Clinical Trials

Leukemia

Acute Lymphoblastic Leukemia

• AALL0232: Phase III—High-risk, B-precursor acute lymphoblastic leukemia
  Principal investigator: Cindy Schwartz, MD

• AALL02P2: Phase III—Treatment of late, isolated extramedullary relapse from acute lymphoblastic leukemia
  Principal investigator: Cindy Schwartz, MD

• AALL0331: Phase III—Standard risk B-precursor acute lymphoblastic leukemia
  Principal investigator: Cindy Schwartz, MD

• AALL03B1: Phase N/A —Classification of acute lymphoblastic leukemia
  Principal investigator: Cindy Schwartz, MD

• DFCI06373: Phase III —Health-related quality of life assessment of pediatric acute lymphoblastic leukemia patients; randomized to receive intravenous versus intramuscular asparaginase
  Principal investigator: Cindy Schwartz, MD

• AALL03N1: Phase N/A —Understanding the ethnic and racial differences in survival in children with acute lymphoblastic leukemia
  Principal investigator: Cindy Schwartz, MD

• DFCI05-001: Phase III —Treatment of acute lymphoblastic leukemia in children
  Principal investigator: Cindy Schwartz, MD

Other

• AE24: Phase N/A: Epidemiology of infant leukemia
  Principal investigator: Cindy Schwartz, MD

For more information about these clincial trials and how to participate, please call 401-444-HOPE (4673). For general information about clinical trials please visit the National Cancer Institute.

Back